UCLA Health Jonsson Comprehensive Cancer Center

A UCLA-led review found there is not yet enough real-world evidence to determine whether using AI in routine screening actually reduces the number of breast cancers diagnosed between screenings

A UCLA study found that traditional pathological features do not predict who will benefit more from adding hormone therapy to postoperative radiation. 

A gene expression test identified the first 3 years after childbirth as a potential window of higher biological risk in breast cancer.

A new UCLA study suggests the organization of immune cells inside melanoma tumors may help show which patients benefit from combination immunotherapy

Low-cost blood tests that detect multiple blood cancers and diseases have been developed by researchers at UCLA Health.

UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling